CCRN
Cross Country HealthcareCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The bull case is now mostly deal-based rather than operational: a signed $13.25 cash transaction sits slightly above the May 7 anchor price of $13.09, so holders can capture a modest spread if the transaction closes on schedule. Q1 revenue topping guidance and sequential nurse/allied growth also reduce near-term break-risk concerns.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.2.
What can break
If the merger fails, investors refocus on a business that reported Q1 revenue down 18% year over year and adjusted EBITDA of just $3.9 million.
Momentum
42
Value
62
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $13.10 · Bull $13.25 · Bear $9.75
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $12.83
Why
Momentum42 · Δ7d -2.8
Value62 · Δ7d +0.2
Sentiment51 · Δ7d -2.9
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
42
26% active weight
Current posture
7d trendImproving
Δ7d
-2.8
Δ21d
-28.1
Value
62
39% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+0.8
Sentiment
51
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.9
Δ21d
-1.3
Why this grade
Composite grade C. Momentum 41.7 / Value 62.2 / Sentiment 51.1
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$427.74M
Beta
0.44
Shares Out
32.31M
P/E (TTM) · Derived
-4.5
P/S (TTM)
0.25
P/FCF (TTM)
6.10
Rev YoY
-17.8%
EPS YoY
+792.1%
Gross Margin
+18.6%
Op Margin
-1.4%
Net Debt
-$106.42M
Current Ratio
3.29
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology

